
Hexis Lab is a technology company specializing in AI-driven sustainable product development and innovation for the beauty, skincare, personal care, nutraceuticals, and pharmaceutical industries. Their proprietary AI platform, HexisPro.X, enables the discovery and prediction of bioactive ingredients and formulations by analyzing vast biochemical and clinical data, accelerating R&D, reducing costs, and overcoming bottlenecks. They offer services including discovery of new ingredients, testing and optimizing products with bespoke cellular assays, and creating and licensing sustainable products. Hexis Lab collaborates with leading brands, including Fortune 500 skincare companies, to develop novel, effective, and sustainable formulations that meet modern consumer demands and support claims substantiation. Their approach combines advanced AI, biological insights, and sustainability to create market-leading products with faster go-to-market timelines.

Hexis Lab is a technology company specializing in AI-driven sustainable product development and innovation for the beauty, skincare, personal care, nutraceuticals, and pharmaceutical industries. Their proprietary AI platform, HexisPro.X, enables the discovery and prediction of bioactive ingredients and formulations by analyzing vast biochemical and clinical data, accelerating R&D, reducing costs, and overcoming bottlenecks. They offer services including discovery of new ingredients, testing and optimizing products with bespoke cellular assays, and creating and licensing sustainable products. Hexis Lab collaborates with leading brands, including Fortune 500 skincare companies, to develop novel, effective, and sustainable formulations that meet modern consumer demands and support claims substantiation. Their approach combines advanced AI, biological insights, and sustainability to create market-leading products with faster go-to-market timelines.
Founded: 2013
Headquarters: Newcastle upon Tyne, United Kingdom
Core focus: AI-driven discovery of sustainable bioactive ingredients and formulation support for beauty, personal care, nutraceuticals and pharma-adjacent products
Proprietary product: HexisPro.X — AI platform for in-silico discovery and screening
Team size (reported): 13 employees
Slow, costly product development and ingredient discovery in cosmetics, personal care and related industries; need for sustainability and substantiated efficacy.
2013
Biotechnology
490000
Six-figure Innovate UK grant reported to support development of sustainable ingredients using synthetic biology
“Innovate UK; other named investors reported include Northstar Ventures and Novotech Investments”